Blue Owl Tumbles as Investor Withdrawals Stop, Market Reacts
Blue Owl Capital halted quarterly redemptions for its OBDC II fund and plans distributions funded by asset sales, tri...
Learn how to choose a low-fee Dividend Aristocrats ETF and what fees to watch. This intro covers cost factors and quick tips for a cost-efficient selection.
24,603 articlesBlue Owl Capital halted quarterly redemptions for its OBDC II fund and plans distributions funded by asset sales, tri...
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Standard Chartered trims its XRP outlook to $2.80, a 65% drop that marks the sharpest forecast revision among its cry...
Two tech giants are racing to dominate AI. This guide breaks down why Alphabet and Amazon could be the better artific...
When a high-profile artist steps away for health, the financial ripple is real—not just for the performer, but for sp...
Rate launches RateFi to allow crypto holders to qualify for mortgages using digital assets as income and reserves, wi...
Carvana's 2025 earnings outlook centers on cash flow, balance-sheet repair, and smarter growth. This guide breaks dow...
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
The FDA has issued a recall of Elite Treats Chicken Chips for Dogs due to potential salmonella contamination. No illn...
A 10% pullback is a normal market event, not a forecast of doom. Here’s what typically happens after a 10% drop and h...
Axon Enterprise stock soared higher after a solid earnings beat and a ambitious revenue goal. This article breaks dow...
A wave of review requests is reshaping consumer habits and small-business budgets in early 2026. Experts warn of a fe...